tiprankstipranks
Processa Pharmaceuticals (PCSA)
NASDAQ:PCSA
US Market

Processa Pharmaceuticals (PCSA) Financial Statements

85 Followers

Processa Pharmaceuticals Financial Overview

Processa Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-23.243; its P/E ratio is -0.10; Processa Pharmaceuticals is scheduled to report earnings on March 28, 2024, and the estimated EPS forecast is $-1.60. See an overview of income statement, balance sheet, and cash flow financials.
Jun 23Mar 23Dec 22Sep 22Jun 22
Income Statement-
Total Revenue---$ 0.00$ 0.00
Gross Profit-----
EBIT$ -2.61M$ -4.02M$ -13.07M$ -6.06M$ -5.16M
EBITDA$ -2.61M$ -4.02M$ -12.83M$ -5.86M$ -4.97M
Net Income Common Stockholders$ -2.61M$ 4.19M$ -13.04M$ -6.02M$ -5.16M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 8.70M$ 10.74M$ 6.50M$ 9.05M$ 12.06M
Total Assets$ 10.09M$ 12.43M$ 8.62M$ 18.60M$ 21.66M
Total Debt$ 191.22K$ 210.52K$ 229.45K$ 247.97K$ 31.21K
Net Debt$ -8.51M$ -10.53M$ -6.27M$ -8.81M$ -12.03M
Total Liabilities$ 930.74K$ 2.29M$ 1.15M$ 1.36M$ 1.58M
Stockholders Equity$ 9.16M$ 10.14M$ 7.47M$ 17.24M$ 20.08M
Cash Flow-
Free Cash Flow$ -2.09M$ -2.10M$ -2.50M$ -2.97M$ -2.33M
Operating Cash Flow$ -2.09M$ -2.10M$ -2.50M$ -2.97M$ -2.33M
Investing Cash Flow-----
Financing Cash Flow-$ 6.40M$ -53.60K$ -35.25K$ 0.00
Currency in USD

Processa Pharmaceuticals Earnings and Revenue History

Processa Pharmaceuticals Debt to Assets

Processa Pharmaceuticals Cash Flow

Processa Pharmaceuticals Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis